IMSB301

· ImmuneSensor Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMSB301, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies [Phase 1]